Statement Of Financial Position [Abstract]

Xspray Pharma - Filing #690674

Concept	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Property, plant and equipment	64 603 SEK	—	—	—	—	44 601 SEK	—	—	—	—	—	—	—	—	—
Right-of-use assets	2 477 SEK	—	—	—	—	3 526 SEK	—	—	—	—	—	—	—	—	—
Non-current assets	453 200 SEK	—	—	—	—	340 838 SEK	—	—	—	—	—	—	—	—	—
Current assets [abstract]
Current inventories	8 552 SEK	—	—	—	—	6 199 SEK	—	—	—	—	—	—	—	—	—
Trade and other current receivables	2 362 SEK	—	—	—	—	2 473 SEK	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	120 166 SEK	—	—	—	—	271 881 SEK	—	—	—	—	325 598 SEK	—	—	—	—
Current assets	132 229 SEK	—	—	—	—	282 065 SEK	—	—	—	—	—	—	—	—	—
Assets	585 430 SEK	—	—	—	—	622 903 SEK	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	22 680 SEK	—	—	—	—	20 680 SEK	—	—	—	—	—	—	—	—	—
Retained earnings	375 057 SEK	—	—	—	—	243 387 SEK	—	—	—	—	—	—	—	—	—
Other reserves	976,000 SEK	—	—	—	—	976,000 SEK	—	—	—	—	—	—	—	—	—
Equity attributable to owners of parent	556 019 SEK	—	—	—	—	591 752 SEK	—	—	—	—	—	—	—	—	—
Equity	556 019 SEK	375 057 SEK	22 680 SEK	976,000 SEK	907 420 SEK	591 752 SEK	243 387 SEK	976,000 SEK	813 483 SEK	20 680 SEK	582 587 SEK	18 893 SEK	146 689 SEK	976,000 SEK	709 407 SEK
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current liabilities	560,000 SEK	—	—	—	—	1 185 SEK	—	—	—	—	—	—	—	—	—
Current liabilities [abstract]
Current liabilities	28 851 SEK	—	—	—	—	29 966 SEK	—	—	—	—	—	—	—	—	—
Equity and liabilities	585 430 SEK	—	—	—	—	622 903 SEK	—	—	—	—	—	—	—	—	—